
A Setback for Implantable Markers: Hologic’s BioZorb Faces FDA Scrutiny
Summary The FDA issued a warning letter to Hologic regarding its BioZorb implantable markers due to safety concerns and failure to meet good manufacturing practices. The company has ceased production of BioZorb following numerous adverse […]